ResearcherZhongda Hospital Southeast UniversityActive in the last 2 years
Zhang Xiu
Matched on ORCID iD 0000-0001-9398-4077; OpenAlex author ID A5100603767. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- [Expression of Concern] ETS‑1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer. Co-author DOI 10.3892/ijo.2025.5786↗
- ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer. Co-author DOI 10.3892/ijo.2016.3770↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cailian Wang · 2 shared papers, 2017–2025 · strength 0.39
- Paper [Expression of Concern] ETS‑1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism … DOI 10.3892/ijo.2025.5786↗
- Paper ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer. DOI 10.3892/ijo.2016.3770↗
- Dan Wu · 2 shared papers, 2017–2025 · strength 0.39
- Paper [Expression of Concern] ETS‑1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism … DOI 10.3892/ijo.2025.5786↗
- Paper ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer. DOI 10.3892/ijo.2016.3770↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.